California confirms third human case of bird flu, finds more possible cases
Adds data on U.S. cattle infections in paragraph 4; CDC comments in paragraphs 6, 11
By Tom Polansek
CHICAGO, Oct 9 (Reuters) -California reported a third human case of bird flu on Wednesday in a dairy worker whohad contact with infected cattle and said the stateidentified two more possible cases in people.
Officials in the most populous U.S. state expect to confirm additional cases in people who have contact with infected dairy cattle, the California Department of Public Health said.
The outlook for more cases follows a surge in infections of dairy cows in the biggest milk-producing U.S. state.
Nearly 300 dairy herds across 14 states tested positive so far this year, with about a third of the cases found in California since late August, according to the U.S. Department of Agriculture. Pasteurized milk and dairy products remain safe to consume, California's public health department said.
A total of 16 people exposed to dairy cows and poultry have tested positive nationwide in 2024. Another person in Missouri who had no immediate known contact with animals also tested positive.
The U.S. Centers for Disease Control and Prevention said that cases in people exposed to infected animals are "not unexpected." Risks to the general public are low, the CDC said.
The virus' jump to cattle and infections of farm workers have worried scientists and federal officials about the risks to humans.
There is no known link or contact between any of California's confirmed or possible cases, suggesting the virus spread from animals to humans in the state and not from person to person, the California Department of Public Health said.
All of the people had contact with animals at different farms and experienced mild symptoms, including eye redness or discharge, the department said. It said none were hospitalized.
Last week, Californiareported two human cases in dairy workers.
In those cases, there were no genetic changes to the virus observed that are known to be associated with an increased ability to infect or spread between people, the CDC said. There were also no changes known to reduce susceptibility to antiviral medications, the agency said.
Reporting by Tom Polansek, editing by Deepa Babington and David Gregorio
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
